Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tele-Harm Reduction for Rapid Initiation of Antiretrovirals in People Who Inject Drugs: a Randomized Controlled Trial

NCT05208697 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT05208697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05208697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tele-Harm Reduction for Rapid Initiation of Antiretrovirals in People Who Inject Drugs: a Randomized Controlled Trial
Lead sponsor
University of Miami
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2022
Completion date
April 30, 2026
Enrollment
100 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, hiv infections, iv drug usage